These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28576241)

  • 1. Rational Selection and Use of Antimicrobials in Patients with Burn Injuries.
    Hill DM; Sinclair SE; Hickerson WL
    Clin Plast Surg; 2017 Jul; 44(3):521-534. PubMed ID: 28576241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infections in critically ill burn patients.
    Hidalgo F; Mas D; Rubio M; Garcia-Hierro P
    Med Intensiva; 2016 Apr; 40(3):179-85. PubMed ID: 27013315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical antimicrobials in pediatric burn wound management.
    Patel PP; Vasquez SA; Granick MS; Rhee ST
    J Craniofac Surg; 2008 Jul; 19(4):913-22. PubMed ID: 18650712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The basic principles of the antibiotic therapy of burn patients].
    Leseva M; Khadzhiĭski O; Grigorov G; Dimitrova A
    Khirurgiia (Sofiia); 1995; 48(3):8-11. PubMed ID: 8667589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of Optimal Amikacin Dosing Regimens for Pediatric Patients With Burn Wound Sepsis.
    Yu T; Stockmann C; Healy DP; Olson J; Wead S; Neely AN; Kagan RJ; Spigarelli MG; Sherwin CM
    J Burn Care Res; 2015; 36(4):e244-52. PubMed ID: 25185930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and Pharmacodynamics of Antimicrobial Agents in Burn Patients.
    Pruskowski KA
    Surg Infect (Larchmt); 2021 Feb; 22(1):77-82. PubMed ID: 33164665
    [No Abstract]   [Full Text] [Related]  

  • 7. Microbiology of burn wound infections.
    Polavarapu N; Ogilvie MP; Panthaki ZJ
    J Craniofac Surg; 2008 Jul; 19(4):899-902. PubMed ID: 18650708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of Imipenem/Cilastatin Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration.
    Boucher BA; Hudson JQ; Hill DM; Swanson JM; Wood GC; Laizure SC; Arnold-Ross A; Hu ZY; Hickerson WL
    Pharmacotherapy; 2016 Dec; 36(12):1229-1237. PubMed ID: 27862103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection control in burn patients.
    Heggers JP; Robson MC
    Clin Plast Surg; 1986 Jan; 13(1):39-47. PubMed ID: 3956082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotics in childhood burns.
    Rowlands RJ; Roland D
    Burns; 2011 Mar; 37(2):359-60. PubMed ID: 20947258
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk factors for outbreaks of multidrug-resistant Klebsiella pneumoniae in critical burn patients.
    Sánchez M; Herruzo R; Marbán A; Araujo P; Asensio MJ; Leyva F; Casado C; García-de-Lorenzo A
    J Burn Care Res; 2012; 33(3):386-92. PubMed ID: 21979841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimicrobial treatment in burn injury patients].
    Trupkovic T; Gille J; Fischer H; Kleinschmidt S
    Anaesthesist; 2012 Mar; 61(3):249-51, 254-6, 258. PubMed ID: 22430556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of dosing regimens and dosing in special populations.
    Sime FB; Roberts MS; Roberts JA
    Clin Microbiol Infect; 2015 Oct; 21(10):886-93. PubMed ID: 25980350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [N1-metal sulfa drugs and zincpolyanemine and its derivatives in prevention of burn wound sepsis].
    Ge SD
    Zhonghua Wai Ke Za Zhi; 1982 May; 20(5):264-6. PubMed ID: 7128331
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of tobramycin pharmacokinetics in burn patients to evaluate the potential utility of once-daily dosing in this population.
    Vella D; Walker SA; Walker SE; Daneman N; Simor A
    J Burn Care Res; 2014; 35(4):e240-9. PubMed ID: 24043237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of oral antibiotic suppression for control of infections in patients with thermal injuries.
    Jarrett F; Balish E; Moylan JA
    J Surg Res; 1978 Apr; 24(4):339-42. PubMed ID: 642502
    [No Abstract]   [Full Text] [Related]  

  • 17. Gap analysis of pharmacokinetics and pharmacodynamics in burn patients: a review.
    Steele AN; Grimsrud KN; Sen S; Palmieri TL; Greenhalgh DG; Tran NK
    J Burn Care Res; 2015; 36(3):e194-211. PubMed ID: 25942648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of aminosides in the burn patient].
    Galizia JP; Besse MD; Goldstein P; Marson JC; Crépy A; Pellerin P
    Cah Anesthesiol; 1986 Oct; 34(6):495-9. PubMed ID: 3801960
    [No Abstract]   [Full Text] [Related]  

  • 19. Amikacin population pharmacokinetics among paediatric burn patients.
    Sherwin CM; Wead S; Stockmann C; Healy D; Spigarelli MG; Neely A; Kagan R
    Burns; 2014 Mar; 40(2):311-8. PubMed ID: 23876785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of meropenem in burn patients.
    Doh K; Woo H; Hur J; Yim H; Kim J; Chae H; Han S; Yim DS
    J Antimicrob Chemother; 2010 Nov; 65(11):2428-35. PubMed ID: 20817742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.